Deardorf Caren 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Deardorf Caren
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-11+25,000→ 25,000 totalExercise: $19.30Exp: 2032-03-10→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable in three substantially equal annual installments on each of the first three anniversaries of the grant date, subject to continued service as a director through each such vesting date.